fosamaxinjurylawsuitcenter - Forside
If you or someone you know have been determined with porous bones, it is not difficult to agree with the presumption that anti-resorptive drugs such as Fosamax may have assumed a role in your life. It may be also less difficult to imagine how you may have come to know the potentially harmful effects and lawsuits related to the widely distributed drug. The Fosamax Injury Lawsuit Center features relevant and up-to-date information about Fosamax and compensatory claims involving the popular osteoporosis drug’s side effects.
osteoprosis_Fosamax.jpg
Alongside a medication’s therapeutic effects is the risk of mild to severe side effects, medical experts say. This scientific notion goes the same for anti-bone degeneration drugs. Where osteoporosis treatment is involved, antiresorptive bisphosphonate drugs reportedly became the mainstay treatment for porous bones, taking the place of hormone therapy in women, after the introduction of the prime anti-bone loss drug popularly known as Fosamax. 

Otherwise known by its generic equivalent, alendronate, Fosamax is an anti-osteoporosis drug originally manufactured and distributed by American pharmaceutical firm, Merck & Co. As soon as the medication was released in late 1995, Fosamax reportedly emerged as one of the most prescribed formulations nationwide, being the pioneering osteoporosis medication to be sold in the United States market. 

Much like other bisphosphonates, Fosamax primarily functions by slowing down the rate of bone loss by changing the cycle of bone breakdown and formation, which in turn decreases a patient’s fractural risk, the most dire consequence of osteoporosis. It was indicated to prevent and treat porous bones in older men and ageing women beyond their menopause, including patients with secondary osteoporosis from the long-term use of steroids. Fosamax is also known to increase bone mineral density in men with osteoporosis, and used to treat Paget\\’s disease of the bone in men and women. 

Although most patients reported a high threshold toward the common side effects of Fosamax, rare yet potentially serious side effects, including thighbone fractures and a rare jaw disease known as osteonecrosis of the jaw, have also been tied to Fosamax use. Current researchers also show a growing number of scientific evidences demonstrating a possible link between Fosamax and esophageal cancer, as well as atrial fibrillation (irregular heart rhythms).


Sources:
breastcancer.org/tips/new_research/20110223.jsp
medicalnewstoday.com/articles/93195.php
medpagetoday.com/Endocrinology/Osteoporosis/13665
acaai.org/allergist/asthma/conditions/osteoporosis-and-asthma/Pages/osteoporosis-medications.aspx
cancerhelp.cancerresearchuk.org/about-cancer/cancer-questions/about-bisphosphonates-and-jaw-problems#link
nejm.org/doi/full/10.1056/NEJMc0707493
 
Panel title
Antal besøg: 431

Lav en gratis hjemmeside på Freewebsite-service.com

Editing

-0,58633613586426sekunder